The core activity of lino Biotech AG is the development and manufacture of instruments and technologies for measuring biological interactions, particularly for the analysis of protein-protein interactions, membrane receptors, and immune receptors. The company offers products and services that enable researchers to observe and quantify biological processes in real-time without the need for labeling or other interfering factors. lino Biotech AG's technologies are specifically used in the areas of hit validation, binder development, and cell and gene therapy.